期刊文献+

迟发性运动障碍的临床研究进展 被引量:5

Research progress on the therapy of tardive dyskinesia
原文传递
导出
摘要 迟发性运动障碍(TD)是一种以不自主舞蹈样或徐动样运动为特征的运动障碍,与长期使用多巴胺受体阻断剂有关。本文综述TD的流行病学特征、病理生理机制以及临床诊断和治疗研究进展。 Tardive dyskinesia (TD) is characterized by involuntary choreiform or athetoid movements, which is related to long-term use of dopamine receptor blocking agents. This review provides an update on TD, including its epidemiology, pathophysiology, diagnosis and therapy.
出处 《世界临床药物》 CAS 2014年第10期I0012-I0017,共6页 World Clinical Drug
基金 资金资助:上海市重性精神病重点实验室(编号:13dz2260500)
关键词 迟发性运动障碍 迟发性综合征 多巴胺受体阻断剂 抗精神病药物 tardive dyskinesia tardive syndrome dopamine receptor blocking agent antipsychotics
  • 相关文献

参考文献35

  • 1Granacher RP. Differential diagnosis of tardive dyskinesia: an overview[J]. Am J Psychiatry, 1981, 138 (10) : 1288-1297.
  • 2Wain O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment[J]. Tremor Other Hyperkinet Mov, 2013, 3.
  • 3Association AP. Diagnostic and statistical manual of mental disorders. Fifth Edition[M]. Arlington, VA: American Psychiatric Association, 2013.
  • 4Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia [J]. Acta Psychiatr Scand, 1996, 94(2): 118-124.
  • 5Yassa R, Jeste DV. Gender differences in tardive dyskinesia: a critical review of the literature [J]. Schizophrenia Bulletin, 1992, 18 (4) : 701-715.
  • 6Chong SA, Tay JAM, Subramaniam M, et al. Mortality rates among patients with schizophrenia and tardive dyskinesia[J]. J Clinical Psychopharmacol, 2009, 29 (1) : 5-8.
  • 7Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: therapeutic options for an increasingly common disorder [J]. Neurotherapeutics, 2014, 11 (1): 166-176.
  • 8Teo JT, Edwards M J, Bhatia K. Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis [J]. Mov Disord, 2012, 27(10) : 1205-1215.
  • 9Alabed S, Latifeh Y, Mohammad HA, et al. Gamma- aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia [J]. Cochrane Database Syst Rev, 2011, CD000203.
  • 10Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanisms and tardive dyskinesia [J]. CNS Drugs, 2003, 17 (1) : 47-62.

二级参考文献14

共引文献16

同被引文献30

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部